N/A
Completed N=50
Adherence to Care for Children With Congenital Zika Virus Infection in Puerto Rico
Zika Virus Infection · Adherence, Patient
Source: ClinicalTrials.gov NCT05041439 ↗
Enrolled (actual)
50
Serious AEs
2.0%
Results posted
Dec 2023
Primary outcomePrimary: Number of Participants With Adherence to Pediatric Zika Care — 14; 15 Participants
Summary
Given the magnitude of the epidemic in Puerto Rico, congenital Zika virus infection may have devastating complications to a significant population of children, also affecting families and society at large. This proposal takes a critical first step to ensuring that children with exposure to congenital Zika virus infection receive the follow-up care they need for optimal clinical outcomes. We anticipate that lessons learned from this study may also positively impact models for adherence to early intervention services in Puerto Rico.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Adherence to Pediatric Zika Care |
6; 5 | — |
| SECONDARY Number of Participants With Detection of Zika-associated Birth Defect or Neurodevelopmental Abnormality |
1; 4 | — |
| SECONDARY Number of Participants With Adherence to Pediatric Zika Care |
6; 5 | — |
Eligibility Criteria
Inclusion Criteria
- Age 18 years or older and able to communicate in Spanish
- Being the primary caregiver of a child with possible congenital Zika virus infection
Exclusion Criteria
- Those who are too sick/unable to understand the implications of their participation, those who are unwilling to participate.
Data sourced from ClinicalTrials.gov (NCT05041439). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.